Furthermore, in agreement with the TCGA and CGGA data, our IHC TMA results revealed that patients with glioma and high IRAK1 expression had a worse OS than those with low IRAK1 expression (Fig. 5F). The gene discussed is IRAK1; the disease is central nervous system cancer.